About Nordic Nanovector
Nordic Nanovector is a company based in Oslo (Norway) founded in 2009.. Nordic Nanovector has raised $51.69 million across 12 funding rounds from investors including European Commission, Norwegian Research Council and Healthcap. The company has 40 employees as of December 31, 2021. Nordic Nanovector has completed 1 acquisition, including THOR Photomedicine. Nordic Nanovector operates in a competitive market with competitors including Regeneron Pharmaceuticals, Mereo BioPharma, Ultragenyx, Sutro Biopharma and Ascendis Pharma, among others.
- Headquarter Oslo, Norway
- Employees 40 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$51.69 M (USD)
in 12 rounds
-
Latest Funding Round
-
Investors
European Commission
& 3 more
-
Employee Count
40
as on Dec 31, 2021
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Nordic Nanovector
Nordic Nanovector has successfully raised a total of $51.69M across 12 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Last Round
-
First Round
First Round
(05 Jun 2013)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2022 | Amount | Post-IPO - Nordic Nanovector | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Nordic Nanovector | Valuation |
investors |
|
| Sep, 2020 | Amount | Post-IPO - Nordic Nanovector | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nordic Nanovector
Nordic Nanovector has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Commission, Norwegian Research Council and Healthcap. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Research policy advice is provided to the Norwegian government.
|
Founded Year | Domain | Location | |
|
Institution of the European Union responsible for upholding the EU treaties
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nordic Nanovector
Nordic Nanovector has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include THOR Photomedicine. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Devices for Low Level Light therapy for pain and inflammation reduction
|
1993 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Nordic Nanovector
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nordic Nanovector Comparisons
Competitors of Nordic Nanovector
Nordic Nanovector operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Regeneron Pharmaceuticals, Mereo BioPharma, Ultragenyx, Sutro Biopharma and Ascendis Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibodies are developed for treating cancer, eye, and inflammatory diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Long-acting prodrug therapies are developed for endocrine and rare diseases.
|
|
| domain | founded_year | HQ Location |
Antibody-drug conjugates are developed for cancer treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nordic Nanovector
Frequently Asked Questions about Nordic Nanovector
When was Nordic Nanovector founded?
Nordic Nanovector was founded in 2009 and raised its 1st funding round 4 years after it was founded.
Where is Nordic Nanovector located?
Nordic Nanovector is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.
Is Nordic Nanovector a funded company?
Nordic Nanovector is a funded company, having raised a total of $51.69M across 12 funding rounds to date. The company's 1st funding round was a Post-IPO of $24.87M, raised on Jun 05, 2013.
How many employees does Nordic Nanovector have?
As of Dec 31, 2021, the latest employee count at Nordic Nanovector is 40.
What does Nordic Nanovector do?
Nordic Nanovector was founded in 2009 in Oslo, Norway, within the biotechnology sector. Antibody radionuclide conjugates are developed by the company for treating haematological cancers. Operations center on innovative therapies, with the lead product Betalutin comprising an anti-CD37 antibody linked to Lutetium 177 for non-Hodgkin Lymphoma. Research and development activities are conducted to advance targeted treatments in oncology.
Who are the top competitors of Nordic Nanovector?
Nordic Nanovector's top competitors include Sutro Biopharma, Regeneron Pharmaceuticals and Mereo BioPharma.
How many acquisitions has Nordic Nanovector made?
Nordic Nanovector has made 1 acquisition, including THOR Photomedicine.
Who are Nordic Nanovector's investors?
Nordic Nanovector has 4 investors. Key investors include European Commission, Norwegian Research Council, Healthcap, and Holta Life Sciences.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.